M, C., S, H., S, D., & L, P. (2025). Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease. Clinical and experimental gastroenterology, 18, 233. https://doi.org/10.2147/CEG.S521893
Chicago Style (17th ed.) CitationM, Colwill, Honap S, Danese S, and Peyrin-Biroulet L. "Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease." Clinical and Experimental Gastroenterology 18 (2025): 233. https://doi.org/10.2147/CEG.S521893.
MLA (9th ed.) CitationM, Colwill, et al. "Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease." Clinical and Experimental Gastroenterology, vol. 18, 2025, p. 233, https://doi.org/10.2147/CEG.S521893.
Warning: These citations may not always be 100% accurate.